Loading...
Champions Oncology, Inc.
CSBR•NASDAQ
Healthcare
Biotechnology
$7.37
$0.00(0.00%)
Champions Oncology, Inc. (CSBR) Financial Performance & Statements
Review Champions Oncology, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-6.90%
↓ 6.90%
Operating Income Growth
-65.34%
↓ 65.34%
Net Income Growth
-36.38%
↓ 36.38%
Operating Cash Flow Growth
-255.17%
↓ 255.17%
Operating Margin
11.48%
↑ 11.48%
Gross Margin
52.19%
↑ 52.19%
Net Profit Margin
10.97%
↑ 10.97%
ROE
656.65%
↑ 656.65%
ROIC
62.51%
↑ 62.51%
Champions Oncology, Inc. (CSBR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Champions Oncology, Inc. stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $13.49M | $14.06M | $14.001M | $12.02M |
| Cost of Revenue | $7.07M | $7.07M | $7.25M | $7.85M |
| Gross Profit | $6.42M | $6.99M | $6.75M | $4.17M |
| Gross Profit Ratio | $0.48 | $0.50 | $0.48 | $0.35 |
| R&D Expenses | $1.69M | $1.45M | $2.05M | $2.19M |
| SG&A Expenses | $3.64M | $4.21M | $4.54M | $4.56M |
| Operating Expenses | $5.33M | $5.66M | $6.59M | $6.75M |
| Total Costs & Expenses | $12.40M | $12.73M | $13.84M | $14.60M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $399000.00 | $449000.00 | $457000.00 | $1.26M |
| EBITDA | $1.13M | $1.78M | $621000.00 | -$2.10M |
| EBITDA Ratio | $0.08 | $0.13 | $0.04 | -$0.11 |
| Operating Income | $732000.00 | $1.33M | $164000.00 | -$2.58M |
| Operating Income Ratio | $0.05 | $0.09 | $0.01 | -$0.21 |
| Other Income/Expenses (Net) | $7000.00 | $5000.00 | $81000.00 | $58000.00 |
| Income Before Tax | $739000.00 | $1.33M | -$191000.00 | -$2.52M |
| Income Before Tax Ratio | $0.05 | $0.09 | -$0.01 | -$0.21 |
| Income Tax Expense | $11000.00 | $21000.00 | -$82000.00 | $11000.00 |
| Net Income | $728000.00 | $1.31M | -$109000.00 | -$2.53M |
| Net Income Ratio | $0.05 | $0.09 | -$0.008 | -$0.21 |
| EPS | $0.05 | $0.10 | -$0.008 | -$0.19 |
| Diluted EPS | $0.05 | $0.09 | -$0.008 | -$0.19 |
| Weighted Avg Shares Outstanding | $13.59M | $13.59M | $13.59M | $13.59M |
| Weighted Avg Shares Outstanding (Diluted) | $14.02M | $14.04M | $13.59M | $13.59M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan